TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
ABSI

Absci Corp

Healthcare · Biotechnology

9.70$ -9.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ABSI
Line item 2019 2020 2021 2022 2023 2024 2025
-292.8% -229.5% -1,267.2% -1,415.3% -1,130.4% -1,596.9% -3,318.8%
23.8% 23.7% 139.1% 227.9% 244.8% 295.3% 419.4%
2.0% 8.8% 221.8% 218.2% 199.7% 429.0% 654.3%
7.3% 26.0% 42.0% 210.0% – – –
-4.3% 21.1% -65.8% -26.8% 26.5% -8.1% 15.1%
53.3% 45.6% 795.6% 281.5% 15.0% 8.9% 39.5%
-52.9% -45.4% -1,409.0% -2,209.5% 1,433.1% -917.0% -1,791.4%
– – 4,399.7% – – – –
115.5% 34.3% 2,580.5% 79.7% -93.5% -88.9% -114.1%
616.8% 1,484.8% 7,030.4% 91.1% -78.4% 1,820.2% 3,783.9%
271.1% 1,209.9% 4,354.2% -3,533.7% 224.3% -693.7% -1,326.3%
-346.1% -275.1% -2,062.8% -1,696.8% -1,145.4% -1,605.8% -3,358.3%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?